ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis Delta Virus (HDV) Infection Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-36V17267
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis Delta Virus HDV Infection Market Research Report 2024
BUY CHAPTERS

Global Hepatitis Delta Virus (HDV) Infection Market Research Report 2024

Code: QYRE-Auto-36V17267
Report
June 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biosidus
Hoffmann-La Roche Ltd
Zydus Cadila
Amega Biotech
Rhein-Minapharm
Probiomed SA de CV
3SBio Group
Eiger BioPharmaceuticals
Arrowhead Pharmaceuticals, Inc.
PharmaEssentia Corporation
Apotex Corp.
Mylan N.V.
Aurobindo Pharma Limited
Gilead Sciences Inc
GlaxoSmithKline PLC
NanoGen Healthcare Pvt. Ltd.
MYR Pharmaceuticals
Hepatera
Janssen Biopharmaceuticals
Antios Therapeutics, Inc.
Replicor, Janssen Pharmaceuticals, Inc

Hepatitis Delta Virus (HDV) Infection Market Size

The global Hepatitis Delta Virus (HDV) Infection market was valued at US$ 1210 million in 2023 and is anticipated to reach US$ 7828 million by 2030, witnessing a CAGR of 30.0% during the forecast period 2024-2030.

Hepatitis Delta Virus (HDV) Infection Market

Hepatitis Delta Virus (HDV) Infection Market

Hepatitis D, also known as delta hepatitis, is a liver infection caused by the Hepatitis D virus (HDV). It is considered a satellite virus, as it requires the presence of the Hepatitis B virus (HBV) to replicate and cause infection. HDV infects individuals either as a co-infection with HBV or as a superinfection in those already infected with HBV. Hepatitis D is caused by the HDV, which can only infect individuals already infected with HBV. HDV can spread through contact with infected blood or body fluids, similar to HBV transmission routes. Injection drug use, exposure to infected blood, or unprotected sexual contact with an HBV/HDV-infected person are common risk factors for acquiring Hepatitis D.
The increasing global prevalence of HDV infection is a significant market driver that is boosting the Market CAGR. HDV infection, which occurs along with hepatitis B virus (HBV) infection, is considered the most severe form of viral hepatitis, resulting in increased morbidity and fatality rates. The World Health Organization (WHO) estimates that over 15-20 million people globally are chronically infected with HDV. This growing incidence of HDV infection highlights the critical need for improved diagnoses, therapies, and preventive measures, which will drive market expansion.
This report aims to provide a comprehensive presentation of the global market for Hepatitis Delta Virus (HDV) Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Delta Virus (HDV) Infection.
The Hepatitis Delta Virus (HDV) Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis Delta Virus (HDV) Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis Delta Virus (HDV) Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hepatitis Delta Virus (HDV) Infection Market Report

Report Metric Details
Report Name Hepatitis Delta Virus (HDV) Infection Market
Accounted market size in 2023 US$ 1210 million
Forecasted market size in 2030 US$ 7828 million
CAGR 30.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Acute Hepatitis D
  • Chronic Hepatitis D
Segment by Application
  • Clinic
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BIOSIDUS, Hoffmann-La Roche Ltd., Zydus Cadila, NanoGen Healthcare Pvt. Ltd., AMEGA Biotech, Rhein-Minapharm, PROBIOMED SA de CV, 3SBio Group, Eiger BioPharmaceuticals, Arrowhead Pharmaceuticals, Inc, MYR Pharmaceuticals, Hepatera, Janssen Biopharmaceuticals, Antios Therapeutics, Inc., PharmaEssentia Corporation, Replicor, Janssen Pharmaceuticals, Inc, Apotex Corp., Mylan N.V, Aurobindo Pharma Limited, Gilead Sciences, Inc., GlaxoSmithKline
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hepatitis Delta Virus (HDV) Infection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hepatitis Delta Virus (HDV) Infection Market growing?

Ans: The Hepatitis Delta Virus (HDV) Infection Market witnessing a CAGR of 30.0% during the forecast period 2024-2030.

What is the Hepatitis Delta Virus (HDV) Infection Market size in 2030?

Ans: The Hepatitis Delta Virus (HDV) Infection Market size in 2030 will be US$ 7828 million.

Who are the main players in the Hepatitis Delta Virus (HDV) Infection Market report?

Ans: The main players in the Hepatitis Delta Virus (HDV) Infection Market are BIOSIDUS, Hoffmann-La Roche Ltd., Zydus Cadila, NanoGen Healthcare Pvt. Ltd., AMEGA Biotech, Rhein-Minapharm, PROBIOMED SA de CV, 3SBio Group, Eiger BioPharmaceuticals, Arrowhead Pharmaceuticals, Inc, MYR Pharmaceuticals, Hepatera, Janssen Biopharmaceuticals, Antios Therapeutics, Inc., PharmaEssentia Corporation, Replicor, Janssen Pharmaceuticals, Inc, Apotex Corp., Mylan N.V, Aurobindo Pharma Limited, Gilead Sciences, Inc., GlaxoSmithKline

What are the Application segmentation covered in the Hepatitis Delta Virus (HDV) Infection Market report?

Ans: The Applications covered in the Hepatitis Delta Virus (HDV) Infection Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Hepatitis Delta Virus (HDV) Infection Market report?

Ans: The Types covered in the Hepatitis Delta Virus (HDV) Infection Market report are Acute Hepatitis D, Chronic Hepatitis D

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acute Hepatitis D
1.2.3 Chronic Hepatitis D
1.3 Market by Application
1.3.1 Global Hepatitis Delta Virus (HDV) Infection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis Delta Virus (HDV) Infection Market Perspective (2019-2030)
2.2 Global Hepatitis Delta Virus (HDV) Infection Growth Trends by Region
2.2.1 Global Hepatitis Delta Virus (HDV) Infection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hepatitis Delta Virus (HDV) Infection Historic Market Size by Region (2019-2024)
2.2.3 Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Region (2025-2030)
2.3 Hepatitis Delta Virus (HDV) Infection Market Dynamics
2.3.1 Hepatitis Delta Virus (HDV) Infection Industry Trends
2.3.2 Hepatitis Delta Virus (HDV) Infection Market Drivers
2.3.3 Hepatitis Delta Virus (HDV) Infection Market Challenges
2.3.4 Hepatitis Delta Virus (HDV) Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis Delta Virus (HDV) Infection Players by Revenue
3.1.1 Global Top Hepatitis Delta Virus (HDV) Infection Players by Revenue (2019-2024)
3.1.2 Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Players (2019-2024)
3.2 Global Hepatitis Delta Virus (HDV) Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hepatitis Delta Virus (HDV) Infection Revenue
3.4 Global Hepatitis Delta Virus (HDV) Infection Market Concentration Ratio
3.4.1 Global Hepatitis Delta Virus (HDV) Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis Delta Virus (HDV) Infection Revenue in 2023
3.5 Global Key Players of Hepatitis Delta Virus (HDV) Infection Head office and Area Served
3.6 Global Key Players of Hepatitis Delta Virus (HDV) Infection, Product and Application
3.7 Global Key Players of Hepatitis Delta Virus (HDV) Infection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis Delta Virus (HDV) Infection Breakdown Data by Type
4.1 Global Hepatitis Delta Virus (HDV) Infection Historic Market Size by Type (2019-2024)
4.2 Global Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Type (2025-2030)
5 Hepatitis Delta Virus (HDV) Infection Breakdown Data by Application
5.1 Global Hepatitis Delta Virus (HDV) Infection Historic Market Size by Application (2019-2024)
5.2 Global Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hepatitis Delta Virus (HDV) Infection Market Size (2019-2030)
6.2 North America Hepatitis Delta Virus (HDV) Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024)
6.4 North America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis Delta Virus (HDV) Infection Market Size (2019-2030)
7.2 Europe Hepatitis Delta Virus (HDV) Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024)
7.4 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size (2019-2030)
8.2 Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size by Region (2019-2024)
8.4 Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis Delta Virus (HDV) Infection Market Size (2019-2030)
9.2 Latin America Hepatitis Delta Virus (HDV) Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024)
9.4 Latin America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size (2019-2030)
10.2 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024)
10.4 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BIOSIDUS
11.1.1 BIOSIDUS Company Details
11.1.2 BIOSIDUS Business Overview
11.1.3 BIOSIDUS Hepatitis Delta Virus (HDV) Infection Introduction
11.1.4 BIOSIDUS Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.1.5 BIOSIDUS Recent Development
11.2 Hoffmann-La Roche Ltd.
11.2.1 Hoffmann-La Roche Ltd. Company Details
11.2.2 Hoffmann-La Roche Ltd. Business Overview
11.2.3 Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Introduction
11.2.4 Hoffmann-La Roche Ltd. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.2.5 Hoffmann-La Roche Ltd. Recent Development
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Details
11.3.2 Zydus Cadila Business Overview
11.3.3 Zydus Cadila Hepatitis Delta Virus (HDV) Infection Introduction
11.3.4 Zydus Cadila Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.3.5 Zydus Cadila Recent Development
11.4 NanoGen Healthcare Pvt. Ltd.
11.4.1 NanoGen Healthcare Pvt. Ltd. Company Details
11.4.2 NanoGen Healthcare Pvt. Ltd. Business Overview
11.4.3 NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Introduction
11.4.4 NanoGen Healthcare Pvt. Ltd. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.4.5 NanoGen Healthcare Pvt. Ltd. Recent Development
11.5 AMEGA Biotech
11.5.1 AMEGA Biotech Company Details
11.5.2 AMEGA Biotech Business Overview
11.5.3 AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Introduction
11.5.4 AMEGA Biotech Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.5.5 AMEGA Biotech Recent Development
11.6 Rhein-Minapharm
11.6.1 Rhein-Minapharm Company Details
11.6.2 Rhein-Minapharm Business Overview
11.6.3 Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Introduction
11.6.4 Rhein-Minapharm Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.6.5 Rhein-Minapharm Recent Development
11.7 PROBIOMED SA de CV
11.7.1 PROBIOMED SA de CV Company Details
11.7.2 PROBIOMED SA de CV Business Overview
11.7.3 PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Introduction
11.7.4 PROBIOMED SA de CV Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.7.5 PROBIOMED SA de CV Recent Development
11.8 3SBio Group
11.8.1 3SBio Group Company Details
11.8.2 3SBio Group Business Overview
11.8.3 3SBio Group Hepatitis Delta Virus (HDV) Infection Introduction
11.8.4 3SBio Group Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.8.5 3SBio Group Recent Development
11.9 Eiger BioPharmaceuticals
11.9.1 Eiger BioPharmaceuticals Company Details
11.9.2 Eiger BioPharmaceuticals Business Overview
11.9.3 Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Introduction
11.9.4 Eiger BioPharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.9.5 Eiger BioPharmaceuticals Recent Development
11.10 Arrowhead Pharmaceuticals, Inc
11.10.1 Arrowhead Pharmaceuticals, Inc Company Details
11.10.2 Arrowhead Pharmaceuticals, Inc Business Overview
11.10.3 Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Introduction
11.10.4 Arrowhead Pharmaceuticals, Inc Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.10.5 Arrowhead Pharmaceuticals, Inc Recent Development
11.11 MYR Pharmaceuticals
11.11.1 MYR Pharmaceuticals Company Details
11.11.2 MYR Pharmaceuticals Business Overview
11.11.3 MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Introduction
11.11.4 MYR Pharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.11.5 MYR Pharmaceuticals Recent Development
11.12 Hepatera
11.12.1 Hepatera Company Details
11.12.2 Hepatera Business Overview
11.12.3 Hepatera Hepatitis Delta Virus (HDV) Infection Introduction
11.12.4 Hepatera Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.12.5 Hepatera Recent Development
11.13 Janssen Biopharmaceuticals
11.13.1 Janssen Biopharmaceuticals Company Details
11.13.2 Janssen Biopharmaceuticals Business Overview
11.13.3 Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Introduction
11.13.4 Janssen Biopharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.13.5 Janssen Biopharmaceuticals Recent Development
11.14 Antios Therapeutics, Inc.
11.14.1 Antios Therapeutics, Inc. Company Details
11.14.2 Antios Therapeutics, Inc. Business Overview
11.14.3 Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Introduction
11.14.4 Antios Therapeutics, Inc. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.14.5 Antios Therapeutics, Inc. Recent Development
11.15 PharmaEssentia Corporation
11.15.1 PharmaEssentia Corporation Company Details
11.15.2 PharmaEssentia Corporation Business Overview
11.15.3 PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Introduction
11.15.4 PharmaEssentia Corporation Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.15.5 PharmaEssentia Corporation Recent Development
11.16 Replicor, Janssen Pharmaceuticals, Inc
11.16.1 Replicor, Janssen Pharmaceuticals, Inc Company Details
11.16.2 Replicor, Janssen Pharmaceuticals, Inc Business Overview
11.16.3 Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Introduction
11.16.4 Replicor, Janssen Pharmaceuticals, Inc Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.16.5 Replicor, Janssen Pharmaceuticals, Inc Recent Development
11.17 Apotex Corp.
11.17.1 Apotex Corp. Company Details
11.17.2 Apotex Corp. Business Overview
11.17.3 Apotex Corp. Hepatitis Delta Virus (HDV) Infection Introduction
11.17.4 Apotex Corp. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.17.5 Apotex Corp. Recent Development
11.18 Mylan N.V
11.18.1 Mylan N.V Company Details
11.18.2 Mylan N.V Business Overview
11.18.3 Mylan N.V Hepatitis Delta Virus (HDV) Infection Introduction
11.18.4 Mylan N.V Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.18.5 Mylan N.V Recent Development
11.19 Aurobindo Pharma Limited
11.19.1 Aurobindo Pharma Limited Company Details
11.19.2 Aurobindo Pharma Limited Business Overview
11.19.3 Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Introduction
11.19.4 Aurobindo Pharma Limited Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.19.5 Aurobindo Pharma Limited Recent Development
11.20 Gilead Sciences, Inc.
11.20.1 Gilead Sciences, Inc. Company Details
11.20.2 Gilead Sciences, Inc. Business Overview
11.20.3 Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Introduction
11.20.4 Gilead Sciences, Inc. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.20.5 Gilead Sciences, Inc. Recent Development
11.21 GlaxoSmithKline
11.21.1 GlaxoSmithKline Company Details
11.21.2 GlaxoSmithKline Business Overview
11.21.3 GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Introduction
11.21.4 GlaxoSmithKline Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
11.21.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biosidus
Hoffmann-La Roche Ltd
Zydus Cadila
Amega Biotech
Rhein-Minapharm
Probiomed SA de CV
3SBio Group
Eiger BioPharmaceuticals
Arrowhead Pharmaceuticals, Inc.
PharmaEssentia Corporation
Apotex Corp.
Mylan N.V.
Aurobindo Pharma Limited
Gilead Sciences Inc
GlaxoSmithKline PLC
NanoGen Healthcare Pvt. Ltd.
MYR Pharmaceuticals
Hepatera
Janssen Biopharmaceuticals
Antios Therapeutics, Inc.
Replicor, Janssen Pharmaceuticals, Inc
List of Tables
 Table 1. Global Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Acute Hepatitis D
 Table 3. Key Players of Chronic Hepatitis D
 Table 4. Global Hepatitis Delta Virus (HDV) Infection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Hepatitis Delta Virus (HDV) Infection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Hepatitis Delta Virus (HDV) Infection Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Hepatitis Delta Virus (HDV) Infection Market Share by Region (2019-2024)
 Table 8. Global Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Hepatitis Delta Virus (HDV) Infection Market Share by Region (2025-2030)
 Table 10. Hepatitis Delta Virus (HDV) Infection Market Trends
 Table 11. Hepatitis Delta Virus (HDV) Infection Market Drivers
 Table 12. Hepatitis Delta Virus (HDV) Infection Market Challenges
 Table 13. Hepatitis Delta Virus (HDV) Infection Market Restraints
 Table 14. Global Hepatitis Delta Virus (HDV) Infection Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Hepatitis Delta Virus (HDV) Infection Market Share by Players (2019-2024)
 Table 16. Global Top Hepatitis Delta Virus (HDV) Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Delta Virus (HDV) Infection as of 2023)
 Table 17. Ranking of Global Top Hepatitis Delta Virus (HDV) Infection Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Hepatitis Delta Virus (HDV) Infection Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Hepatitis Delta Virus (HDV) Infection, Headquarters and Area Served
 Table 20. Global Key Players of Hepatitis Delta Virus (HDV) Infection, Product and Application
 Table 21. Global Key Players of Hepatitis Delta Virus (HDV) Infection, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Hepatitis Delta Virus (HDV) Infection Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Type (2019-2024)
 Table 25. Global Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Type (2025-2030)
 Table 27. Global Hepatitis Delta Virus (HDV) Infection Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Application (2019-2024)
 Table 29. Global Hepatitis Delta Virus (HDV) Infection Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Application (2025-2030)
 Table 31. North America Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Country (2025-2030) & (US$ Million)
 Table 46. BIOSIDUS Company Details
 Table 47. BIOSIDUS Business Overview
 Table 48. BIOSIDUS Hepatitis Delta Virus (HDV) Infection Product
 Table 49. BIOSIDUS Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 50. BIOSIDUS Recent Development
 Table 51. Hoffmann-La Roche Ltd. Company Details
 Table 52. Hoffmann-La Roche Ltd. Business Overview
 Table 53. Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Product
 Table 54. Hoffmann-La Roche Ltd. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 55. Hoffmann-La Roche Ltd. Recent Development
 Table 56. Zydus Cadila Company Details
 Table 57. Zydus Cadila Business Overview
 Table 58. Zydus Cadila Hepatitis Delta Virus (HDV) Infection Product
 Table 59. Zydus Cadila Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 60. Zydus Cadila Recent Development
 Table 61. NanoGen Healthcare Pvt. Ltd. Company Details
 Table 62. NanoGen Healthcare Pvt. Ltd. Business Overview
 Table 63. NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Product
 Table 64. NanoGen Healthcare Pvt. Ltd. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 65. NanoGen Healthcare Pvt. Ltd. Recent Development
 Table 66. AMEGA Biotech Company Details
 Table 67. AMEGA Biotech Business Overview
 Table 68. AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Product
 Table 69. AMEGA Biotech Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 70. AMEGA Biotech Recent Development
 Table 71. Rhein-Minapharm Company Details
 Table 72. Rhein-Minapharm Business Overview
 Table 73. Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Product
 Table 74. Rhein-Minapharm Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 75. Rhein-Minapharm Recent Development
 Table 76. PROBIOMED SA de CV Company Details
 Table 77. PROBIOMED SA de CV Business Overview
 Table 78. PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Product
 Table 79. PROBIOMED SA de CV Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 80. PROBIOMED SA de CV Recent Development
 Table 81. 3SBio Group Company Details
 Table 82. 3SBio Group Business Overview
 Table 83. 3SBio Group Hepatitis Delta Virus (HDV) Infection Product
 Table 84. 3SBio Group Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 85. 3SBio Group Recent Development
 Table 86. Eiger BioPharmaceuticals Company Details
 Table 87. Eiger BioPharmaceuticals Business Overview
 Table 88. Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Product
 Table 89. Eiger BioPharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 90. Eiger BioPharmaceuticals Recent Development
 Table 91. Arrowhead Pharmaceuticals, Inc Company Details
 Table 92. Arrowhead Pharmaceuticals, Inc Business Overview
 Table 93. Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product
 Table 94. Arrowhead Pharmaceuticals, Inc Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 95. Arrowhead Pharmaceuticals, Inc Recent Development
 Table 96. MYR Pharmaceuticals Company Details
 Table 97. MYR Pharmaceuticals Business Overview
 Table 98. MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Product
 Table 99. MYR Pharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 100. MYR Pharmaceuticals Recent Development
 Table 101. Hepatera Company Details
 Table 102. Hepatera Business Overview
 Table 103. Hepatera Hepatitis Delta Virus (HDV) Infection Product
 Table 104. Hepatera Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 105. Hepatera Recent Development
 Table 106. Janssen Biopharmaceuticals Company Details
 Table 107. Janssen Biopharmaceuticals Business Overview
 Table 108. Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Product
 Table 109. Janssen Biopharmaceuticals Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 110. Janssen Biopharmaceuticals Recent Development
 Table 111. Antios Therapeutics, Inc. Company Details
 Table 112. Antios Therapeutics, Inc. Business Overview
 Table 113. Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Product
 Table 114. Antios Therapeutics, Inc. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 115. Antios Therapeutics, Inc. Recent Development
 Table 116. PharmaEssentia Corporation Company Details
 Table 117. PharmaEssentia Corporation Business Overview
 Table 118. PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Product
 Table 119. PharmaEssentia Corporation Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 120. PharmaEssentia Corporation Recent Development
 Table 121. Replicor, Janssen Pharmaceuticals, Inc Company Details
 Table 122. Replicor, Janssen Pharmaceuticals, Inc Business Overview
 Table 123. Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product
 Table 124. Replicor, Janssen Pharmaceuticals, Inc Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 125. Replicor, Janssen Pharmaceuticals, Inc Recent Development
 Table 126. Apotex Corp. Company Details
 Table 127. Apotex Corp. Business Overview
 Table 128. Apotex Corp. Hepatitis Delta Virus (HDV) Infection Product
 Table 129. Apotex Corp. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 130. Apotex Corp. Recent Development
 Table 131. Mylan N.V Company Details
 Table 132. Mylan N.V Business Overview
 Table 133. Mylan N.V Hepatitis Delta Virus (HDV) Infection Product
 Table 134. Mylan N.V Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 135. Mylan N.V Recent Development
 Table 136. Aurobindo Pharma Limited Company Details
 Table 137. Aurobindo Pharma Limited Business Overview
 Table 138. Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Product
 Table 139. Aurobindo Pharma Limited Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 140. Aurobindo Pharma Limited Recent Development
 Table 141. Gilead Sciences, Inc. Company Details
 Table 142. Gilead Sciences, Inc. Business Overview
 Table 143. Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Product
 Table 144. Gilead Sciences, Inc. Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 145. Gilead Sciences, Inc. Recent Development
 Table 146. GlaxoSmithKline Company Details
 Table 147. GlaxoSmithKline Business Overview
 Table 148. GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Product
 Table 149. GlaxoSmithKline Revenue in Hepatitis Delta Virus (HDV) Infection Business (2019-2024) & (US$ Million)
 Table 150. GlaxoSmithKline Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Hepatitis Delta Virus (HDV) Infection Picture
 Figure 2. Global Hepatitis Delta Virus (HDV) Infection Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Hepatitis Delta Virus (HDV) Infection Market Share by Type: 2023 VS 2030
 Figure 4. Acute Hepatitis D Features
 Figure 5. Chronic Hepatitis D Features
 Figure 6. Global Hepatitis Delta Virus (HDV) Infection Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Hepatitis Delta Virus (HDV) Infection Market Share by Application: 2023 VS 2030
 Figure 8. Clinic Case Studies
 Figure 9. Hospital Case Studies
 Figure 10. Others Case Studies
 Figure 11. Hepatitis Delta Virus (HDV) Infection Report Years Considered
 Figure 12. Global Hepatitis Delta Virus (HDV) Infection Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Hepatitis Delta Virus (HDV) Infection Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Hepatitis Delta Virus (HDV) Infection Market Share by Region: 2023 VS 2030
 Figure 15. Global Hepatitis Delta Virus (HDV) Infection Market Share by Players in 2023
 Figure 16. Global Top Hepatitis Delta Virus (HDV) Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Delta Virus (HDV) Infection as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Hepatitis Delta Virus (HDV) Infection Revenue in 2023
 Figure 18. North America Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Hepatitis Delta Virus (HDV) Infection Market Share by Country (2019-2030)
 Figure 20. United States Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Hepatitis Delta Virus (HDV) Infection Market Share by Country (2019-2030)
 Figure 24. Germany Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Hepatitis Delta Virus (HDV) Infection Market Share by Region (2019-2030)
 Figure 32. China Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Hepatitis Delta Virus (HDV) Infection Market Share by Country (2019-2030)
 Figure 40. Mexico Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Share by Country (2019-2030)
 Figure 44. Turkey Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Hepatitis Delta Virus (HDV) Infection Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. BIOSIDUS Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 48. Hoffmann-La Roche Ltd. Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 49. Zydus Cadila Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 50. NanoGen Healthcare Pvt. Ltd. Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 51. AMEGA Biotech Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 52. Rhein-Minapharm Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 53. PROBIOMED SA de CV Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 54. 3SBio Group Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 55. Eiger BioPharmaceuticals Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 56. Arrowhead Pharmaceuticals, Inc Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 57. MYR Pharmaceuticals Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 58. Hepatera Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 59. Janssen Biopharmaceuticals Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 60. Antios Therapeutics, Inc. Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 61. PharmaEssentia Corporation Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 62. Replicor, Janssen Pharmaceuticals, Inc Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 63. Apotex Corp. Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 64. Mylan N.V Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 65. Aurobindo Pharma Limited Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 66. Gilead Sciences, Inc. Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 67. GlaxoSmithKline Revenue Growth Rate in Hepatitis Delta Virus (HDV) Infection Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global HDV ELISA Kits Market Research Report 2024
Hepatitis B Infectious Disease Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis D Virus Antibody Test Kit Market Research Report 2024
Hepatitis B Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Hepatitis C Drugs Market Research Report 2024
Dengvaxia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dengue Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2025
Hepatitis C Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis C Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis C Virus Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral Drugs for the Treatment of Hepatitis C HCV Market Research Report 2024
Global Bovine Viral Diarrhea Virus BVDV Test Kits Market Research Report 2024
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis B Virus Nucleic Acid Detection Kit Market Research Report 2024
Chronic Hepatitis B Virus Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Direct Acting Antivirals Market Research Report 2024
Hepatitis B Vaccines Market
Global Compensated Cirrhosis Type C Market Research Report 2024
Global BVDV Detection Kit Market Research Report 2024

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions